Charity Number: 1159219
Heart Valve Voice
Report and financial statements for the year ended 31st March 2025
Heart Valve Voice
Reference and administrative information
for the year ended 31 March 2025
Charity number 1159219
Registered office and operational address
St Wilfrid’s Enterprise Centre, Royce Road, Hulme, Manchester, M15 5BJ
Trustees Trustees who served during the year and up to the date of this report were as follows:
Christopher Young Chair Keith Jackson Treasurer Amanda Bott Susan Alderton Chris Arden Alison Banayoti Prof Simon Ray Phil Read Angela Martin Dr Yassir Javaid Rick Steeds Key management Wil Woan Executive Director personnel Callum Fergusson Head of Content Bankers Lloyds TSB P.O.Box 250, Skelmersdale, WN8 6WT Independent Jennifer Daniel FCCA DChA, Slade & Cooper Limited Examiner Beehive Mill, Jersey St, Manchester, M4 6JG
1
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
The trustees present their report and the unaudited financial statements for the year ended 31 March 2025
Reference and administrative information set out on page 1 forms part of this report. The financial statements comply with current statutory requirements, the charity’s constitution and the Statement of Recommended Practice - Accounting and Reporting by Charities: SORP
Objectives and activities
The main purpose of the charity is to raise awareness of the symptoms and severity of heart valve disease in the UK in order to save lives and improve quality of life; whilst increasing the awareness of symptoms of heart valve disease such as breathlessness and dizziness and improve diagnosis
These aims are summarised under the following core outcomes:
(a) to assist in the diagnosis treatment management and care of persons suffering from heart valve disease by the raising awareness and providing support to effective and timely treatments;
(b) to promote and protect the physical and mental health of sufferers of heart valve disease in the UK through the provision of financial assistance, support, education and practical advice;
(c) to advance the education of the general public in all areas relating to heart valve disease
The trustees review the aims, objectives and activities of the charity each year. This report looks at what the charity has achieved and the outcomes of its work in the reporting period. The trustees report the success of each key activity and the benefits the charity has brought to those groups of people that it is set up to help. The review also helps the trustees ensure the charity’s aims, objectives and activities remain focused on its stated purposes.
The trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular, the trustees consider how planned activities will contribute to the aims and objectives that have been set.
The trustees review the aims, objectives and activities of the charity each year. This report looks at what the charity has achieved and the outcomes of its work in the reporting period. The trustees report the success of each key activity and the benefits the charity has brought to those groups of people that it is set up to help. The review also helps the trustees ensure the charity’s aims, objectives and activities remain focused on its stated purposes.
The trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular, the trustees consider how planned activities will contribute to the aims and objectives set.
2
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
Achievements and performance
The period from April 2024 to Mach 2025 marked an important and confident chapter for Heart Valve Voice. As the charity approaches its second decade, this year has been defined by renewed momentum, stronger partnerships, growing patient influence, and a continued focus on tackling late diagnosis, inequality, and variation in heart valve disease care. Across media, policy, clinical engagement and community outreach, patient voice has remained central to everything we do.
To address the ongoing challenges facing heart valve disease patients in accessing timely diagnosis and treatment, we have continued to build on our strategic priorities:
-
Implementing a National Heart Valve Disease Awareness Campaign that reaches patients, healthcare professionals, and policymakers.
-
Expanding our visibility and delivering activities that unite and engage key stakeholders.
-
Strengthening our engagement with policymakers to ensure heart valve disease remains a public health priority.
-
Amplifying the Patient Voice to highlight inequalities and under-treatment across the UK.
During the financial year, we have made significant progress towards these aims, delivering impactful events, high-profile media campaigns, and policy engagement activities that have furthered our mission.
Media and Public Education
During the year, Heart Valve Voice launched the Know Your Heart campaign, an educational initiative designed to improve public understanding of heart health and heart valve disease. The campaign focused on increasing awareness of symptoms, encouraging earlier conversations, and supporting people to seek timely assessment. Through accessible messaging and patient stories, Know Your Heart contributed to wider public engagement and reinforced the importance of early detection.
Media activity throughout the year continued to position Heart Valve Voice as a trusted national voice for patients, supporting informed discussion around diagnosis, treatment choice, and quality of life.
Heart Valve Voice’s educational “SLOW” animation reached a significant milestone during the year, achieving over one million views. Developed as part of a wider awareness campaign, the animation helps people recognise the key symptoms of heart valve disease — Shortness of breath, Lightheadedness on exertion, feeling Older than your years, and Weary. This level of reach highlights the ongoing need for improved awareness and earlier detection of heart valve disease, which affects an estimated 1.5 million people over the age of 65 in the UK. By extending the reach of clear, accessible information, Heart Valve Voice continues to support earlier diagnosis and timely access to treatment
Parliamentary Engagement and Advocacy
Advocacy remained a cornerstone of our work. We continued to support the role of our External Clinical Director, strengthening the bridge between patient experience, clinical leadership, and policy development.
3
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
Heart Valve Voice played a key role in patient engagement during Late Stage Assessment processes, contributing insight on device choice, shared decision making, and patient priorities. This ensured that patient perspectives were meaningfully reflected at critical points in the evaluation of new technologies.
A major milestone this year was the establishment of the Women’s Clinical Advisory Group, created to address persistent inequalities in the diagnosis, treatment, and outcomes of women with heart valve disease. This group brings together clinical expertise and lived experience to inform research, advocacy, and future policy engagement.
In February, we held a heart valve disease testing and awareness event at the Houses of Parliament. The event engaged over 55 parliamentarians, providing an opportunity to raise awareness of the issues affecting patients, the importance of early detection, and the impact of delayed diagnosis. As a result of this engagement, a number of politicians have since gone on to actively support the charity in a range of ways, strengthening Heart Valve Voice’s parliamentary relationships and advocacy impact.
We were pleased to be approached by the Medicines and Healthcare products Regulatory Agency (MHRA) to support the creation of a patient panel focused on new devices and clinical trials, further embedding patient voice within regulatory processes.
Patients supported by Heart Valve Voice also contributed to the West Midlands Endocarditis Working Group, and we provided vital patient insight to the South London Valve Inequity Steering Group, ensuring lived experience informed regional pathway development.
In addition, Heart Valve Voice was instrumental in supporting a successful grant for Wythenshawe Hospital, addressing challenges related to sustaining funding and protecting the financial health of services supporting valve patients.
We also began new connections with the Women’s Health All-Party Parliamentary Group, delivering a dedicated roundtable to discuss key issues facing women with heart valve disease and highlighting the urgent need for system-wide change.
Awareness and Patient Engagement
Heart Valve Voice continued to elevate patient voice across national and international platforms. We presented at major UK and international conferences, ensuring patient experience remained visible alongside clinical and academic discussion.
Patients supported by the charity spoke at a range of events, including Oxford Live, sharing personal stories that brought clarity and humanity to complex clinical topics. We also participated in World Heart Day, amplifying messages around awareness, prevention, and early diagnosis.
Two community testing events in Edinburgh and Lancaster were a major highlight of the year. These events offered free heart checks to the public and created space for important conversations about heart valve disease. Across the two locations, over 300 hearts were listened to, with more than 30 people identified as having a previously undetected cardiac condition, demonstrating the real-world impact of community-based engagement. We also carried out testing events in Manchester, Leicester, Cardiff and Newcastle.
4
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
We also celebrated powerful patient-led achievements. Heart Valve Voice was proud to share the story of Marina, a heart valve disease patient who successfully climbed Scafell Pike. Her determination and resilience showcased the possibilities of life after treatment and inspired patients and supporters alike.
This year also saw national recognition of our “SLOW” animation, designed to raise awareness of heart valve disease symptoms. The animation was formally endorsed by the UK’s major professional cardiovascular societies, reinforcing its credibility and value as an educational tool.
Finally, we proudly marked Heart Valve Voice’s 10th anniversary. Over the past decade, the charity has grown into a trusted platform for patient empowerment and a catalyst for meaningful change in heart valve care. Since registering as a charity in 2014, we have ensured that patient stories, experiences, and needs are at the centre of conversations about heart valve disease, helping to shape better policy, improve diagnostic pathways, and increase awareness of a condition that too often goes unnoticed.
Newsletter and Communications
Throughout the year, Heart Valve Voice continued to deliver a regular newsletter reaching over 1,000 clinicians, patients, and supporters. The newsletter has been a key channel for consistently disseminating timely information, guidance, and insight on issues affecting patients with heart valve disease. By sharing updates on policy developments, clinical guidance, patient opportunities, and awareness campaigns, the newsletter helps ensure that both professionals and patients remain informed, connected, and engaged in improving care and outcomes.
10[th] Anniversary Celebration
Heart Valve Voice marked its 10th anniversary with a special celebration attended by over 100 guests, including patients, clinicians, policymakers, and key stakeholders. The event showcased the charity’s achievements over the past decade and highlighted the collective impact of collaboration between patients and professionals. Crucially, the celebration also created space to reflect on what matters most to patients, using lived experience to inform future priorities and reinforce the importance of keeping patient voice at the heart of heart valve disease care.
Financial review
During the year, we have reduced a number of liabilities and strengthened the charity’s overall financial position. The introduction of structured quarterly finance meetings, attended by the Chairman, Treasurer (Trish Bullen), Bookkeeper and Director, has provided clear oversight and accountability, creating a strong platform for financial stabilisation and sustainable growth.
Following challenges in previous years, Heart Valve Voice has continued its recovery, with funding levels showing improvement and a broader base of supporters reducing reliance on any single income source. The charity continues to work closely with healthcare industry partners through clearly defined contracts to deliver agreed activities, and we remain committed to maintaining and developing these relationships. While supporter numbers have increased, securing sufficient funding to deliver essential projects remains a challenge.
5
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
Encouragingly, we have strengthened our fundraising portfolio, with a growing number of patients actively raising funds on behalf of the charity. Initiatives such as the Heart Valve Voice Lottery and JustGiving campaigns are generating increasing levels of unrestricted income, providing greater flexibility and resilience.
The Treasurer, Chairman and Chief Executive continue to review financial risk carefully, particularly in relation to expenditure, unrestricted income, and restricted funding streams. As the charity receives income from healthcare industry partners, associated income and expenditure risks are monitored closely. A formal risk assessment covering the period April 2024 to March 2025 has been completed and reviewed by the Board.
Reserves policy
The trustees remain committed to maintaining a prudent level of reserves to ensure the charity’s sustainability and ability to respond to emerging opportunities and risks. Reserves are held to provide financial stability, support continuity of core activities, and protect the charity during periods of income uncertainty. The reserves policy is reviewed regularly by the Board. A risk assessment has been undertaken for the period of April 1 to 31 March 2025. Whilst Charity aims to have 6 months of reserves this has been difficult and the Trustees have agreed to focus on securing unrestricted funding to increase the reserves to 9 months by end of 2025.
Plans for the future
We anticipate an increase in treatment inequalities across the UK, and in particular across the devolved nations, so we are preparing to deliver tailored media and government affairs campaigns to highlight the importance of early detection and timely treatment. It is imperative that all liabilities and deficits are cleared by end of year 2025 and several conversations are in place with donors to help with unrestricted costs.
Structure, governance and management
The charity was incorporated as a charitable incorporated organisation on 14 November 2014. New trustees are appointed by the existing trustees. The governing document is the constitution.
The charity is constituted under a constitution. The trustees are members of the charity but this entitles them only to voting rights. The trustees have no beneficial interest in the charity and are recruited through Trustee meeting discussions and on occasion via advert if specific skills are sought.
All trustees give their time voluntarily and receive no benefits from the charity. Any expenses reclaimed from the charity are set out in note 8 to the accounts.
The charity utilises skills from an independent consultant on constitutional matters and a review
Related parties and relationships with other organisations
Member of the Global Heart Hub
Remuneration policy for key management personnel
The Executive Director, Chairman and Treasurer form a pay committee and review remuneration yearly based on an appraisal system supported by a HR coaching consultant.
6
Heart Valve Voice
Trustees’ annual report
for the year ended 31 March 2025
Risk management
The Chairman and Executive Director review risks every three months. In November 2024, a full review of HR systems took place alongside the recently appointed bookkeeper and Operations Manager. We identified “Failure to maintain adequate funding and secure the financial health of the charity” as a key risk but our funding levels are returning to previous health amounts and we are engaged with new funders.
Statement of responsibilities of the trustees
Law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the charity's financial activities during the period and of its financial position at the end of the period. In preparing financial statements giving a true and fair view, the trustees should follow best practice and:
-
Select suitable accounting policies and then apply them consistently
-
Observe the methods and principles in the Charities SORP
-
Make judgements and estimates that are reasonable and prudent
-
State whether applicable UK Accounting Standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements
-
Prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charity's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
The trustees annual report has been approved by the trustees on /_/2026 and signed on their behalf by:
Keith Jackson Treasurer
7
Independent examiner’s report
to the trustees of
Heart Valve Voice
I report to the charity trustees on my examination of the accounts of the charity for the year ended 31[st] March 2025 which are set out on pages 9 to 20.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Jennifer Daniel FCCA DChA Slade & Cooper Limited, Chartered Certified Accountants Beehive Mill, Jersey Street Manchester, M4 6JG
Date _______
8
Heart Valve Voice
Statement of Financial Activities
for the year ended 31 March 2025
| Unrestricted funds Note £ Income from: Donations and legacies 3 13,006 Charitable activities: 4 100,029 Total income 113,035 Expenditure on: Charitable activities 5 119,523 Total expenditure 119,523 6 (6,488) Transfer between funds - Net movement in funds for the year (6,488) Reconciliation of funds Total funds brought forward 67,877 Total funds carried forward 61,389 Net income/(expenditure) for the year |
Restricted funds £ - 288,935 288,935 288,935 288,935 - - - - - |
Total funds 2025 £ 13,006 388,964 401,970 408,458 408,458 (6,488) - (6,488) 67,877 61,389 |
Total funds 2024 £ 2,690 380,739 |
|---|---|---|---|
| 383,429 | |||
| 363,120 | |||
| 363,120 | |||
| 20,309 - |
|||
| 20,309 47,568 |
|||
| 67,877 |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
9
Heart Valve Voice
Balance Sheet
as at 31 March 2025
| Note £ £ Fixed assets Tangible assets 9 10,858 Total fixed assets 10,858 Current assets Debtors 10 224,996 Cash at bank and in hand 14,928 Total current assets 239,924 Liabilities Creditors: amounts falling due in less than one year 12 (189,393) Net current assets 50,531 Total assets less current liabilities 61,389 Net assets 61,389 Funds of the charity: Restricted income funds 13 - Unrestricted income funds 14 61,389 Total charity funds 61,389 Keith Jackson (Trustee) 2025 Approved by the trustees on / /2026 and signed on their behalf by: The notes on pages 11 to 20 form part of these accounts. |
£ £ 16,523 16,523 205,000 18,055 223,055 (171,701) 51,354 67,877 67,877 - 67,877 67,877 - 2024 |
£ £ 16,523 16,523 205,000 18,055 223,055 (171,701) 51,354 67,877 67,877 - 67,877 67,877 - 2024 |
|---|---|---|
| 16,523 51,354 |
||
| 67,877 | ||
| 67,877 | ||
| - 67,877 |
||
| 67,877 | ||
| - |
10
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025
1 Accounting policies
The principal accounting policies adopted, judgments and key sources of estimation uncertainty in the preparation of the financial statements are as follows:
a Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), second edition - October 2019 (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011 and UK Generally Accepted Accounting Practice.
The charity has applied the exemption available to small charities in the Charities SORP (FRS 102) and does not include a Statement of Cash Flows in these Financial Statements.
The accounts (financial statements) have been prepared to give a 'true and fair view' and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair view'. This departure has involved following Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), second edition - October 2019, rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
Heart Valve Voice meets the definition of a public benefit entity under FRS102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note.
b Preparation of the accounts on a going concern basis
The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern. There are no key judgments which the trustees have made which have a significant effect on the accounts.
The trustees do not consider that there are any sources of estimation uncertainty at the reporting date that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next reporting period.
11
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
c Income
Income is recognised when the charity has entitlement to the funds, any performance conditions attached to the item(s) of income have been met, it is probable that the income will be received and the amount can be measured reliably.
Income from government and other grants, whether ‘capital’ grants or ‘revenue’ grants, is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred.
Income received in advance of a provision of a specified service is deferred until the criteria for income recognition are met.
d Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the Bank.
e Fund accounting
Unrestricted funds are available to spend on activities that further any of the purposes of charity.
Designated funds are unrestricted funds of the charity which the trustees have decided at their discretion to set aside to use for a specific purpose.
Restricted funds are donations which the donor has specified are to be solely used for particular areas of the charity’s work or for specific projects being undertaken by the charity.
f Expenditure and irrecoverable VAT
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.
Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.
g Tangible fixed assets
Individual fixed assets costing £2,000 or more are capitalised at cost and are depreciated over their estimated useful economic lives on a straight line. There were no fixed assets in
12
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
h Debtors
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
i Cash at bank and in hand
Cash at bank and cash in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
j Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
2 Legal status of the charity
The charity is a charitable incorporated organisation, registered as a charity in England & Wales.
3 Income from donations and legacies
| Donations Total Total by fund 31 March 2024 |
Unrestricted £ 13,006 13,006 2,690 |
Restricted £ - - - |
Total 2025 £ 13,006 13,006 2,690 |
Total 2024 £ 2,690 |
|---|---|---|---|---|
| 2,690 | ||||
13
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
4 Income from charitable activities
| Edward Life Sciences Medtronic Global Hear Rudolf Riester GE Medical Meril UK Limited Boston Scientific Abbott Medical Other Total Total by fund 31 March 2024 |
Unrestricted £ - 80,029 - 20,000 - - - - - 100,029 380,741 |
Restricted £ 205,935 - - - 30,000 30,000 8,000 15,000 - 288,935 - |
Total 2025 £ 205,935 80,029 - 20,000 30,000 30,000 8,000 15,000 - 388,964 380,741 |
Total 2024 £ 290,000 47,848 1,167 30,000 - - - - 11,724 |
|---|---|---|---|---|
| 380,739 | ||||
5 Analysis of expenditure on charitable activities
| Staff costs Professional fees Marketing and design Travel and subsistence Consultancy fees Governance cost Administrative costs Depreciation Restricted expenditure Unrestricted expenditure |
Total 2025 £ 172,773 3,898 98,895 52,433 61,389 1,920 11,485 5,665 408,458 2025 £ 288,935 119,523 408,458 |
Total 2024 160,378 12,706 76,795 25,653 80,981 1,920 4,215 472 |
|---|---|---|
| 363,120 | ||
| 2024 £ - 363,120 |
||
| 363,120 |
14
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
6 Net income/(expenditure) for the year
| This is stated after charging/(crediting): Depreciation Accountant's remuneration - accountancy fees Staff costs Staff costs during the year were as follows: Wages and salaries Social security costs Pension costs - Independent examiner's fees |
2025 £ 5,665 1,000 600 2025 £ 152,832 16,070 3,872 172,774 |
2024 £ 472 1,000 600 |
|---|---|---|
| 2024 £ 142,287 15,041 3,079 |
||
| 160,407 |
7 Staff costs
One employee has employee benefits in excess of £75,000 (2024: One).
The average number of staff employed during the period was 4 (2024: 4).
The key management personnel of the charity comprise the trustees, the Chief Executive Officer and Head of Content. The total employee benefits of the key management personnel of the charity were £124,625 (2024: £118,972).
15
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
8 Trustee remuneration and expenses, and related party transactions
Neither trustees nor any persons connected with them received any remuneration during the year (2024: Nil).
No trustees received travel and subsistence expenses during the year of (2024:£nil).
There are no donations from related parties which are outside the normal course of business and no restricted donations from related parties.
No trustee or other person related to the charity had any personal interest in any contract or transaction entered into by the charity, including guarantees, during the year (2024: nil).
9 Fixed assets: tangible assets
| Cost Additions Disposals Depreciation Charge for the year Disposals Net book value At 31 March 2025 At 31 March 2024 At 1 April 2024 At 31 March 2025 At 1 April 2024 At 31 March 2025 |
Medical equipment £ 16,995 - - |
|---|---|
| 16,995 | |
| 472 5,665 - |
|
| 6,137 | |
| 10,858 | |
| 16,523 |
16
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
10 Debtors
| Grants receivable 11 Cash at bank and in hand Cash at bank and on hand 12 Creditors: amounts falling due within one year Other creditors and accruals Taxation and social security costs |
2025 £ 224,996 224,996 2025 £ 14,928 14,928 2025 £ 16,040 173,353 189,393 |
2024 £ 205,000 |
|---|---|---|
| 205,000 | ||
| 2024 £ 18,055 |
||
| 18,055 | ||
| 2024 £ 18,320 153,381 |
||
| 171,701 |
17
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
13 Analysis of movements in restricted funds
| Edward Life Sciences GE Medical Meril UK Limited Boston Scientific Abbott Medical Total |
Balance at 1 April 2024 £ - - - - - - |
Income £ 205,935 30,000 30,000 8,000 15,000 288,935 |
Expenditure £ (205,935) (30,000) (30,000) (8,000) (15,000) (288,935) |
Transfers £ - - - - - - |
Balance at 31 March 2025 £ - - - - - |
|---|---|---|---|---|---|
| - |
14 Analysis of movement in unrestricted funds
| General fund General fund Previous reporting period Name of General fund |
Balance at 1 April 2024 Income Expenditure Transfers £ £ £ £ 67,877 113,035 (119,523) - 67,877 113,035 (119,523) - Balance at 1 April 2023 Income Expenditure Transfers £ £ £ £ 47,568 383,431 (363,122) - 47,568 383,431 (363,122) - Description, nature and purposes of the fund The free reserves of the charity |
As at 31 March 2025 £ 61,389 |
|---|---|---|
| 61,389 | ||
| As at 31 March 2024 £ 67,877 |
||
| 67,877 | ||
18
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
15 Analysis of net assets between funds
| Net current assets/(liabilities) Total |
General fund £ 50,531 50,531 |
Designated funds £ - - |
Restricted funds £ - - |
Total £ 50,531 |
|---|---|---|---|---|
| 50,531 |
19
Heart Valve Voice
Notes to the accounts for the year ended 31 March 2025 (continued)
16 Prior year Statement of Financial Actvities
| Unrestricted funds Note £ Income from: Donations and legacies 3 2,690 Charitable activities: 4 380,741 Total income 383,431 Expenditure on: Charitable activities 5 363,120 Total expenditure 363,120 6 20,311 Transfer between funds - 20,311 Reconciliation of funds Total funds brought forward 47,568 Total funds carried forward 67,879 Net movement in funds for the year Net income/(expenditure) for the year |
Restricted funds £ - - - - - - - - - - |
Total funds 2024 £ 2,690 380,741 383,431 363,120 363,120 20,311 - 20,311 47,568 67,879 |
Total funds 2023 £ 9,763 480,850 |
|---|---|---|---|
| 490,613 | |||
| 487,886 | |||
| 487,886 | |||
| 2,727 - |
|||
| 2,727 44,841 |
|||
| 47,568 |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
20